Samsung Biologics, CEPI seal $20 mil. vaccine manufacturing partnership
Samsung Biologics is joining hands with the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen vaccine manufacturing for future epidemic and pandemic threats. The company said Wednesday it signed a partnership agreement with CEPI a day earlier to join the organization’s Vaccine Manufacturing Facilities Network, supported by up to $20 million in initial funding. The collaboration will support the development of scalable, rapid manufacturing processes for recombinant protein vaccines, aiming to pre-position a ready-to-activate process that can be deployed quickly when a new viral threat emerges. Samsung Biologics will work with CEPI to help ensure swift global vaccine supply in a future pandemic, with doses produced by the company to be supplied to Korea on a priority basis at CEPI’s request. CEPI is an innovative partnership spanning public, private, philanthropic and civil organizations, formed to support vaccine development and other biologic countermeasures against epidemic and pandemic threats. "This agreement reflects our commitment to supporting a reliable and aWeiter zum vollständigen Artikel bei Korea Times
Ausgewählte Hebelprodukte auf Samsung
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Samsung
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Korea Times
